Organon reported a disappointing Q4, with revenue down 5% YoY and significant weakness in women's health. Shares are heavily oversold, but I maintain a Hold rating due to strategic uncertainty and ...

The convenience store market is projected to grow, and FEMSA trades at a very attractive EV-to-EBITDA multiple relative to its peers. Read why FMX stock is a buy.

Record quarterly revenue of $270.6 million, up 17% QoQ, and record full-year revenue of $852.5 million, up 115% year-over-yearBroadening Scorpio ...

Strong Fourth Quarter and Full Year Results as Latham Continued to Outperform the U.S. In-Ground Pool Market Year-on-Year Margin Expansion Reflected Lower Cost Structure and Cost Discipline, While ...

Full Year 2025 Revenue Growth of 2.5%; Year-Over-Year Revenue Growth on a Constant Currency Basis of 3.9% Full Year 2025 Net Loss of $373.4 Million; Adjusted EBITDA of $19.4 Million Strong Balance ...

Teads Holding Co. (Nasdaq: TEAD) ("Teads" or the "Company") announced today financial results for the quarter and full year ended December 31, 2025. Fourth ...

Company marks first full year as public company with record revenue of $571 million and record net deposits of $8.6 billion, representing a 46% and 91% increase respectively ...

Investing.com - UBS upgraded Melia Hotels (BME:MEL) shares to Neutral from Sell and raised its price target to €8.60 from €6.70, citing improved equity story amid the companys ...

Shares of Upstart Holdings declined after the company's margin forecast missed Wall Street's estimates, owing to shifts in its product mix. The stock fell 15% to $33.06 on Wednesday. Shares have ...

U.S. stocks were trading mostly lower on Wednesday as enthusiasm over the January jobs report quickly faded. The reason has much to do with a number of headwinds that remain, according to Terry ...